Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $3.92 in the prior trading day, Revance Therapeutics Inc (NASDAQ: RVNC) closed at $3.79, down -3.32%. In other words, the price has decreased by -$3.32 from its previous closing price. On the day, 1.16 million shares were traded. RVNC stock price reached its highest trading level at $4.0 during the session, while it also had its lowest trading level at $3.755.
Ratios:
Our goal is to gain a better understanding of RVNC by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.64 and its Current Ratio is at 5.37.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Mizuho on January 29, 2024, Downgraded its rating to Neutral and sets its target price to $9 from $16 previously.
On January 09, 2024, Goldman Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $30 to $8.
Exane BNP Paribas Upgraded its Underperform to Neutral on August 16, 2023, while the target price for the stock was maintained at $20.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 16 ’24 when Jordan Erica sold 2,392 shares for $3.80 per share. The transaction valued at 9,096 led to the insider holds 114,864 shares of the business.
Schilke Tobin sold 9,361 shares of RVNC for $47,204 on Mar 18 ’24. The CFO now owns 192,666 shares after completing the transaction at $5.04 per share. On Mar 18 ’24, another insider, Sjuts Dustin S, who serves as the President of the company, sold 9,211 shares for $5.04 each. As a result, the insider received 46,446 and left with 167,550 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RVNC now has a Market Capitalization of 395861696 and an Enterprise Value of 594564800. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.67. Its current Enterprise Value per Revenue stands at 2.475 whereas that against EBITDA is -2.807.
Stock Price History:
Over the past 52 weeks, RVNC has reached a high of $24.87, while it has fallen to a 52-week low of $2.30. The 50-Day Moving Average of the stock is 24.02%, while the 200-Day Moving Average is calculated to be -30.69%.
Shares Statistics:
The stock has traded on average 2.01M shares per day over the past 3-months and 1993080 shares per day over the last 10 days, according to various share statistics. A total of 104.45M shares are outstanding, with a floating share count of 95.34M. Insiders hold about 8.72% of the company’s shares, while institutions hold 85.21% stake in the company. Shares short for RVNC as of 1721001600 were 16350136 with a Short Ratio of 8.13, compared to 1718323200 on 14352615. Therefore, it implies a Short% of Shares Outstanding of 16350136 and a Short% of Float of 17.969999.
